Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Search results for

  • The Infrastructure Investment and Jobs Act adds the funds over the next five years to help Americans save on energy their bills. But many of homes are in such poor condition they do not qualify.
  • In a substantive edit to Netflix's public-facing statement on work culture, the company states that employees might have to work on titles they "perceive to be harmful."
  • The U.S. Supreme Court hands down split decisions in two closely watched cases regarding the display of the Ten Commandments in public areas. The court ruled against their display in Kentucky courthouses. But it said a monument on the grounds of Texas' capitol did not violate the Constitution.
  • The federal budget deficit has declined somewhat, according to new numbers released by the Congressional Budget Office. An increase in tax revenues caused the latest 2005 budget projections to cut the estimated deficit by $88 billion.
  • Confrontations erupt as Israeli settlers protest their forced removal from the Gaza Strip. The clashes came as other settlers rushed to leave the area before the midnight withdrawal deadline. At least 50 arrests have been reported.
  • A battalion of Marines based in Ohio is mourning the loss of 14 comrades, who died in a roadside bomb attack Wednesday in Iraq's Anbar province. It's the battalion's second loss in three days: six other marines died Monday in the same area.
  • Dennis Rader, the confessed BTK serial killer, receives 10 life sentences for murders committed in Kansas. In June, Rader pleaded guilty to 10 murders that took place between 1974 and 1991.
  • Drugmaker Merck faces more than 7,000 lawsuits related to its painkiller Vioxx. The first of four federal Vioxx trials is slated to begin Tuesday in Houston. The case involves a 53-year-old Florida man who had a fatal heart attack in 2001 after a month on Vioxx.
  • The first federal trial over the painkiller Vioxx begins Tuesday in Houston. Pharmaceutical company Merck has defended its handling of the drug in two previous state cases, losing one of them. Merck withdrew Vioxx from the market last year after a study showed that the drug posed heart risks.
2,633 of 16,501